PRESS RELEASE published on 10/14/2025 at 08:00, 1 month 21 days ago Elis: Disclosure of trading in own shares occured from October 6 to October 8, 2025 Elis discloses trading in own shares from October 6 to October 8, 2025 in compliance with regulations. Shares bought back for employee share plans and cancellation as per resolutions Cancellation Share Buybacks Regulations Elis Employee Share Plans
BRIEF published on 09/23/2025 at 08:05, 2 months 11 days ago Elis Announces Share Buyback Activity from September 15 to 19, 2025 Financial Strategy Share Cancellation Stock Transactions Employee Shareholding Elis Share Buyback
PRESS RELEASE published on 09/23/2025 at 08:00, 2 months 11 days ago Elis: Disclosure of trading in own shares occured from September 15 to September 19, 2025 Elis discloses trading in own shares from Septembre 15 to September 19, 2025, in line with regulations. The purchases were made under an authorized buyback program Own Shares Buyback Program Share Buybacks Regulations Elis
BRIEF published on 09/03/2025 at 07:05, 3 months 1 day ago Elis Launches 2025 Employee Share Ownership Plan Euronext Paris Elis 2025 Launch Employee Share Plan International Offering
PRESS RELEASE published on 09/03/2025 at 07:00, 3 months 1 day ago Elis announces a 2025 “Elis for All” employee share ownership plan Elis introduces 'Elis for All' 2025 employee share ownership plan to enhance employee engagement and ownership. Offering details and subscription conditions outlined Stock Issuance Financial Offering Elis Employee Share Ownership Subscription Conditions
BRIEF published on 08/29/2025 at 10:53, 3 months 6 days ago Elis Announces Share and Voting Rights Update as of July 2025 Voting Rights Shares Investor Relations Elis July 2025
PRESS RELEASE published on 08/29/2025 at 10:48, 3 months 6 days ago Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 07 2025 Elis SA discloses total number of shares, theoretical voting rights, and exercisable voting rights as of July 31, 2025. Details available on www.elis.com Voting Rights Shares Investor Relations Disclosure Elis SA
BRIEF published on 08/28/2025 at 08:05, 3 months 7 days ago Elis Reveals Share Buyback Activities in Late August 2025 Share Buyback Shareholders' Meeting Employee Shares Elis Performance Plans
PRESS RELEASE published on 08/28/2025 at 08:00, 3 months 7 days ago Elis: Disclosure of trading in own shares occured from August 25 to August 26, 2025 Elis discloses trading in own shares from August 25 to August 26, 2025, under buyback program. Shares purchased for employee share plans and to be canceled. Details provided Trading Disclosure Cancellation Share Buybacks Elis Employee Share Plans
BRIEF published on 08/26/2025 at 18:03, 3 months 9 days ago Elis successfully completes €350 million bond placement Investors EMTN Refinancing Bonds Elis
Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
